Neuland Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE794A01010
  • NSEID: NEULANDLAB
  • BSEID: 524558
INR
16,850.00
-138.5 (-0.82%)
BSENSE

Dec 05

BSE+NSE Vol: 11.32 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Neuland Labs.
Emcure Pharma
Astrazeneca Phar
ERIS Lifescience
Sai Life
Pfizer
Alembic Pharma
Wockhardt
Cohance Life
Piramal Pharma
OneSource Speci.
Why is Neuland Laboratories Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.10 times
2
The company has declared positive results in Sep'2025 after 4 consecutive negative quarters
  • OPERATING CF(Y) Highest at Rs 317.38 Cr
  • PAT(Q) At Rs 96.85 cr has Grown at 194.0% (vs previous 4Q average)
  • NET SALES(Q) At Rs 514.27 cr has Grown at 54.7% (vs previous 4Q average)
3
High Institutional Holdings at 34.55%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 0.89% over the previous quarter.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Neuland Labs. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Neuland Labs. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Neuland Labs.
-5.65%
-0.13
49.97%
Sensex
4.67%
0.37
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.73%
EBIT Growth (5y)
20.42%
EBIT to Interest (avg)
18.06
Debt to EBITDA (avg)
0.83
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
0.98
Tax Ratio
23.54%
Dividend Payout Ratio
5.95%
Pledged Shares
0
Institutional Holding
34.55%
ROCE (avg)
18.62%
ROE (avg)
14.60%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
111
Industry P/E
34
Price to Book Value
13.38
EV to EBIT
86.46
EV to EBITDA
66.43
EV to Capital Employed
12.69
EV to Sales
14.20
PEG Ratio
NA
Dividend Yield
0.07%
ROCE (Latest)
14.67%
ROE (Latest)
12.09%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
OPERATING CF(Y)

Highest at Rs 317.38 Cr

PAT(Q)

At Rs 96.85 cr has Grown at 194.0% (vs previous 4Q average

NET SALES(Q)

At Rs 514.27 cr has Grown at 54.7% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 155.54 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 30.24%

PBT LESS OI(Q)

Highest at Rs 127.64 cr.

-3What is not working for the Company
PAT(9M)

At Rs 138.56 cr has Grown at -24.17%

DPR(Y)

Lowest at 5.95%

Loading Valuation Snapshot...
Here's what is working for Neuland Labs.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 127.64 cr has Grown at 230.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 38.68 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 96.85 cr has Grown at 194.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 32.95 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Cash Flow - Annually
Highest at Rs 317.38 Cr and Grown
each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Net Sales - Quarterly
At Rs 514.27 cr has Grown at 54.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 332.50 Cr
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Net Sales - Quarterly
Highest at Rs 514.27 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 155.54 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 30.24%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 127.64 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 96.85 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Neuland Labs.
Dividend Payout Ratio (DPR) - Annually
Lowest at 5.95%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)